Chittorgarh.com Logo
Loading...

CBC Pharma IPO Details

Issue Open Jan 31, 2020
Issue Close Feb 6, 2020
IPO Price ₹51
Face Value ₹10
IPO Size ₹10.20 Cr
Listing At BSE SME
IPO Lot Size 2000
  1. CBC-led Consortium Acquires Significant Equity Interest in Koreas Largest Medical Aesthetics Company

    Tue, 24 Aug 2021 16:53:00 GMT

    This marks the beginning of CBC's journey into the global medical aesthetics sector, in addition to our current pharma, medtech and services exposure. By leveraging our foothold in international ...

  2. CBC-Led Consortium Buys Bainís Hugel Stake For $1.5 Billion

    Wed, 25 Aug 2021 01:11:00 GMT

    (Bloomberg) --South Korean cosmetic pharmaceutical company Hugel Inc. said its largest investor, Bain Capital, has signed a deal to sell a 46.9% stake to a consortium led by private equity firm CBC ...

  3. Glenmark Life Sciences share price falls over 3% as anchor investor lock-in period ends

    Thu, 02 Sep 2021 01:28:00 GMT

    Also Read: Explained: Is the euphoria around IPOs fading? Glenmark Life Sciences, a wholly-owned subsidiary of Glenmark Pharmaceuticals, is a manufacturer of active pharmaceutical ingredients ...

  4. Abu Dhabiís Mubadala part of consortium purchasing Bainís Hugel stake for $1.5bn

    Wed, 25 Aug 2021 02:38:00 GMT

    South Korean cosmetic pharmaceutical company Hugel said its largest investor, Bain Capital, has signed a deal to sell a 46.9 per cent stake to a consortium led by private equity firm CBC Group.

  5. Greater Cincinnati public company inks six-figure deal as merger looms

    Wed, 25 Aug 2021 12:23:00 GMT

    Aerpio Pharmaceuticals (Nasdaq ... Aerpio, which launched a $42 million IPO in 2018, was one of Greater Cincinnatiís better-performing public companies of 2020, as investors poured more into ...

  6. Peptone: Putting molecular physics at the heart of UKs next billion-pound pharma company

    Mon, 13 Sep 2021 16:46:00 GMT

    The founders say that to complete its mission to bring new, innovative drugs to the market, it is open to many different paths ó be that through an IPO or SPAC deal or a merger. And itís not just the ...

  7. InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare Cannabinoids

    Mon, 13 Sep 2021 04:40:00 GMT

    13, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company ... BayMedica's initial rare cannabinoid product, Prodiolģ CBC (cannabichromene), have grown steadily since ...

  8. Bausch Health plans IPO for medical aesthetics business to cut debt

    Tue, 03 Aug 2021 05:51:00 GMT

    Bausch said in March it would sell its entire stake in Egypt's Amoun Pharmaceutical Co SAE and last year announced plans to spin off Bausch + Lomb. Solta's IPO will now create three companies ...

  9. CBC-led Consortium Acquires Significant Equity Interest in Koreas Largest Medical Aesthetics Company

    Tue, 24 Aug 2021 17:21:00 GMT

    joining an industry-leading portfolio in the pharmaceuticals and biotech, medical technology and service sectors. Founded in 2014, CBC has consistently focused on control-oriented acquisitions and ...

  10. CBC-led consortium acquires significant equity interest in Koreas largest medical aesthetics company

    Tue, 24 Aug 2021 23:10:00 GMT

    As CBC continues to build its presence in the Asian healthcare sector, this transaction marks its strategic entrance into the medical aesthetics sector, joining an industry-leading portfolio in the ...

CBC Pharma IPO Alerts

1. CBC Pharma IPO Listing Date & Info  Wednesday, February 12, 2020 6:21:24 AM

The IPO Shares of Chandra Bhagat Pharma Ltd IPO are proposed to list on Friday, February 14, 2020 at BSE SME. The public issue of CBC Pharma IPO was opened on Jan 31, 2020 and closed for subscription on Feb 6, 2020. CBC Pharma IPO Listing Date and Information:

Chandra Bhagat Pharma Ltd Listing Date

Listing DateFriday, February 14, 2020
BSE Script Code542934
NSE Symbol
Listing In
ISININE07QQ01016
Issue PriceRs 51 Per Equity Share
Face ValueRs 10 Per Equity Share

2. CBC Pharma IPO Allotment Status  Tuesday, February 11, 2020 10:50:47 PM

The allotment status of Chandra Bhagat Pharma Ltd IPO is now available online. The public issue of CBC Pharma IPO was open on Jan 31, 2020 and closed for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.

3. CBC Pharma IPO Opens on Jan 31, 2020  Tuesday, January 28, 2020 5:48:57 AM

Chandra Bhagat Pharma Ltd is entering in the capital market with an IPO of 2,000,000 Equity Shares of Rs 10 aggregating up to Rs 10.20 Crore. The price for the issue has been set at Rs 51 Per Equity Share.

Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.

The issue opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME.

4. CBC Pharma IPO Closes on Feb 6, 2020  Tuesday, January 28, 2020 5:48:57 AM

The issue of Chandra Bhagat Pharma Ltd opens on Jan 31, 2020 and closes for subscription on Feb 6, 2020. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.

CBC Pharma IPO News & Events FAQs

The CBC Pharma IPO is proposed to open on Jan 31, 2020. The IPO application ends on Feb 6, 2020.

Retail investors can apply in the retail or non-institutional investor category from Jan 31, 2020 to Feb 6, 2020. The CBC Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The CBC Pharma IPO will open for subscription on Jan 31, 2020. The public issue will close on Feb 6, 2020.